You are here: Industry Insights > Sanofi

News List

Libtayo Monotherapy Trial in Advanced Cervical Cancer Stopped Early for OS Positive Result americanpharmaceuticalreview
March 22, 2021
Regeneron Pharmaceuticals and Sanofi announced positive results demonstrating an overall survival (OS) benefit from the Phase 3 trial investigating the PD-1 inhibitor Libtayo® (cemiplimab) monotherapy compared to chemotherapy, in patients previously ...
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate worldpharmanews
March 19, 2021
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced the start of the Phase 1/2 clinical trial for MRT5500, an mRNA vaccine candidate against SARS-CoV-2 ...
Sanofi, Regeneron’s Libtayo improves survival in cervical cancer patients pharmatimes
March 15, 2021
Sanofi and Regeneron’s PD-1 inhibitor Libtayo has demonstrated positive overall survival (OS) results in a Phase III trial in advanced cervical cancer.
FDA to review Sanofi’s Dupixent in children with uncontrolled asthma pharmatimes
March 05, 2021
The US Food and Drug Administration (FDA) will review Sanofi’s Dupixent as an add-on treatment for children aged six to 11 years with uncontrolled moderate-to-severe asthma.
Sanofi and GSK start Phase II study of their COVID-19 vaccine candidate europeanpharmaceuticalreview
February 25, 2021
The dose finding study will assess the safety, reactogenicity and immunogenicity of the companies’ investigational COVID-19 vaccine in 720 participants.
Sanofi partners with SIRION to improve AAV capsids for gene therapy treatments pharmatimes
February 25, 2021
SIRION Biotech has signed a license and collaboration with Sanofi to develop improved adeno-associated virus capsids for gene therapy treatments for disorders affecting major human organs.
USFDA grants FTD to efanesoctocog alfa for hemophilia A treatment pharmaceutical-business-review
February 25, 2021
The U.S. Food and Drug Administration (FDA) has granted efanesoctocog alfa – earlier termed BIVV001 (rFVIIIFc-VWF-XTEN) – Fast Track Designation (FTD) for the treatment of patients suffering from hemophilia A.
GSK, Sanofi begin new COVID-19 vaccine study after setback expresspharma
February 23, 2021
The companies aim to reach final testing in the second quarter, and if the results are conclusive, hope to see the vaccine approved by the fourth quarter.
US judge orders BMS, Sanofi to pay $834m for illegal marketing of Plavix pharmaceutical-technology
February 18, 2021
US Judge Dean Ochiai has ordered Bristol-Myers Squibb (BMS) and Sanofi to pay over $834m to the state of Hawaii for illegally marketing their blood-thinning drug Plavix.
mRNA COVID-19 vaccine from Sanofi will not ready this year: CEO expresspharma
February 18, 2021
A COVID-19 vaccine candidate developed by Sanofi and US group Translate Bio “will not be ready this year,” said the company’s CEO to Le Journal du Dimanche newspaper.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page